Hull patient becomes the first in the world to trial new Covid treatment
It's designed to prevent the most severe forms of Covid-19
A patient at Hull Royal Infirmary has become the first in the world to trial a new way of combatting the most severe forms of Covid-19.
Iuliana-Alexandra Constantin was taken to hospital with the virus earlier this week, and has now been given an experimental treatment.
Interferon Beta is inhaled by the patient and comes in the form of a mist. The drug is designed to help the lungs battle coronavirus.
Consultant Respiratory Physician Dr Michael Crooks, principal investigator for the trial in Hull, said: “Hull is at the forefront of studying new treatments for Covid 19 and we are currently taking part in a number of trials of potential new therapies.
“The dedication and commitment of our researcher teams mean we are able to offer patients access to potential new treatments against this terrible disease.
“We are hopeful this trial will confirm the effectiveness of inhaled Interferon Beta in helping people recover from the virus and preventing them developing severe disease.”
Researchers say Interferon Beta is a protein that naturally forms in the body, and has been found to help combat Covid-19.
Treatment is then delivered through a nebuliser- a sort of gas mask- which helps prompt a response from the lungs.
Scientists are hoping to give it to those who struggle with their breathing.
It's thought that could stop the virus from progressing in patients, and aid their recovery.
Hull University Teaching Hospitals say: "Hull took part in the Phase 2 trial, involving around 100 people, during the first wave of the pandemic and is playing a major role in Phase 3 by recruiting the first patient to the next phase of the trial."